← Back to headlines
Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-3 Study of TALZENNA®
Pfizer Inc. has announced positive topline results from its Phase 3 TALAPRO-3 study of TALZENNA®, indicating successful outcomes for the drug.
25 Mar, 18:52 — 25 Mar, 18:52
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
WMO Warns of Impending El Niño Return by Mid-2026
just now
Grimme-Preis Awarded to 'Wetten, dass...' Creator Frank Elstner
16m ago
New Fossil Discoveries Confirm Giant Kraken-Like Octopuses Ruled Prehistoric Seas
20m ago